We have recently shown that A20, a negative regulator of NF-κβ, is specifically disrupted in pediatric IBD; despite an observed increase in A20 gene expression, protein levels and associated signaling are reduced, suggesting a pediatric-specific dysregulation of A20 and NF-κβ (12). The gene discussed is TNFAIP3; the disease is inflammatory bowel disease.